Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Carboplatin (DB00958)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00230542Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerTreatment
NCT01248962Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal CancerTreatment
NCT00267696Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerTreatment
NCT00501644Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerTreatment